Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Vijay Kara, MSc, BSc
Director, Safety and Quantitative Innovation
GlaxoSmithKline, United Kingdom
Poster(s):
(183) An Examination of How Serious Infection Are Reported in Spontaneous Reports
Friday, August 26, 2022
8:00 AM – 6:00 PM
CEST
